Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism (EIT-PE)
A Multicenter Retrospective and Prospective Diagnostic Observational Study of Pulsatile Electrical Impedance Tomography for Diagnosis, Risk Stratification, and Dynamic Monitoring of Acute Pulmonary Embolism
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Pulmonary embolism is an important type of venous thromboembolism and may be associated with substantial morbidity and mortality. CT pulmonary angiography is commonly used as the reference standard for diagnosis, but it has limitations, including radiation exposure, use of iodinated contrast agents, and limited feasibility for continuous bedside monitoring in some critically ill patients.
Electrical impedance tomography is a noninvasive functional imaging technique that can be performed at the bedside and does not involve radiation. This study will evaluate a pulsatile EIT-based approach for assessing pulmonary ventilation and perfusion. The main EIT-derived parameters include the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
The retrospective phase will collect existing clinical and EIT data from patients with CTPA-confirmed acute pulmonary embolism and healthy controls. These data will be used to compare EIT parameters between groups, evaluate diagnostic performance, and explore optimal cutoff values.
The prospective phase will enroll patients newly diagnosed with acute pulmonary embolism and healthy volunteers. EIT examinations will be performed during routine clinical evaluation and follow-up. EIT parameters will be compared with CTPA findings, clinical risk stratification, D-dimer levels, echocardiographic indicators, and clinical outcomes. For patients with pulmonary embolism, serial EIT measurements may be used to evaluate dynamic changes during treatment and follow-up.
This is an observational study. Participants will not be assigned to any treatment by the study protocol, and clinical management will be determined by the treating physicians according to routine clinical practice.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: jiazheng LI, MD
- Número de telefone: +86-18810886832
- E-mail: ljzs00357@btch.edu.cn
Estude backup de contato
- Nome: weiwei wu, MD
- Número de telefone: +86-13426397036
- E-mail: weiwei.wu@btch.edu.cn
Locais de estudo
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 102218
- Ainda não está recrutando
- Beijing Tsinghua Changgung Hospital
-
Contato:
- jiazheng LI, MD
- Número de telefone: +86-18810886832
- E-mail: ljzs00357@btch.edu.cn
-
Contato:
- weiwei wu, MD
- Número de telefone: +86-13426397036
- E-mail: weiwei.wu@btch.edu.cn
-
Investigador principal:
- weiwei wu, MD
-
Beijing, Beijing Municipality, China, 100730
- Ainda não está recrutando
- Peking Union Medical College Hospital
-
Contato:
- YUN LONG, MD
- Número de telefone: +86-10-69155707
- E-mail: 2801634102@qq.com
-
Subinvestigador:
- yun long, MD
-
-
Hunan
-
Chenzhou, Hunan, China, 423000
- Recrutamento
- Chenzhou First People's Hospital
-
Contato:
- shaofei xu, MD
- Número de telefone: +86-13617356697
- E-mail: 742025632@qq.com
-
Contato:
- E-mail: 742025632@qq.com
-
Subinvestigador:
- shaofei xu, MD
-
Loudi, Hunan, China, 417000
- Ainda não está recrutando
- Loudi Central Hospital
-
Contato:
- junbiao huang, MD
- Número de telefone: +8618873820320
- E-mail: 695997696@qq.com
-
Subinvestigador:
- junbiao huang, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Adults aged 18 years or older. For retrospective PE cases: patients with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination, adequate image data, and available clinical information.
For retrospective healthy controls: adults without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history.
For prospective PE patients: patients newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, with body mass index less than 50 kg/m², who voluntarily participate and provide written informed consent.
For prospective non-PE controls: patients with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed, who voluntarily participate and provide written informed consent.
Exclusion Criteria:
- Previous diagnosis of chronic pulmonary embolism or idiopathic pulmonary arterial hypertension.
Acute exacerbation of chronic obstructive pulmonary disease, acute heart failure, acute myocardial infarction, or other severe cardiopulmonary diseases that may interfere with study assessment.
Pregnancy or lactation. Thoracic deformity. Contraindications to EIT examination, including automatic implantable cardioverter defibrillator, chest wounds limiting electrode belt placement, implanted pumps, or other conditions unsuitable for EIT electrode belt placement.
Participation in another clinical trial during the same period, for prospective participants.
Unstable vital signs requiring emergency rescue, leaving no time to complete EIT examination, for prospective participants.
Any other condition considered unsuitable for participation by the investigators.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Retrospective PE Cases
Patients aged 18 years or older with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination and available clinical data in the retrospective phase.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
Outros nomes:
|
|
Retrospective Healthy Controls
Adults in the retrospective phase without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
Outros nomes:
|
|
Prospective PE Patients
Patients aged 18 years or older newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, who voluntarily participate and provide written informed consent.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
Outros nomes:
|
|
Prospective Non-PE Controls
Patients aged 18 years or older with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed.
These participants voluntarily participate and provide written informed consent in the prospective phase.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Diagnostic performance of EIT-derived MI, DI, and SI for acute pulmonary embolism
Prazo: At baseline or index EIT assessment
|
The diagnostic performance of EIT-derived ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index for distinguishing acute pulmonary embolism from non-PE controls will be evaluated using the area under the receiver operating characteristic curve, sensitivity, specificity, positive predictive value, negative predictive value, and optimal cutoff values, with CT pulmonary angiography as the reference standard.
|
At baseline or index EIT assessment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Correlation between EIT-derived parameters and CTPA embolic burden
Prazo: At baseline or index assessment
|
The correlation between MI, DI, SI and the embolic burden assessed by CT pulmonary angiography will be analyzed.
|
At baseline or index assessment
|
|
Differences in EIT-derived parameters across thrombus locations and clinical risk strata
Prazo: At baseline or index assessment
|
MI, DI, and SI will be compared among patients with different thrombus locations and different clinical risk strata.
|
At baseline or index assessment
|
|
Correlation between EIT-derived parameters and clinical indicators
Prazo: At baseline or index assessment
|
The correlation between MI, DI, SI and clinical indicators, including D-dimer levels and echocardiographic indicators of right heart function, will be analyzed.
|
At baseline or index assessment
|
|
Dynamic changes in EIT-derived parameters during treatment and follow-up
Prazo: Baseline, 48 hours after thrombolytic treatment when applicable, before discharge, and 1 month after discharge
|
Changes and percentage changes in MI, DI, and SI will be assessed at baseline, during treatment when applicable, before discharge, and at 1 month after discharge.
|
Baseline, 48 hours after thrombolytic treatment when applicable, before discharge, and 1 month after discharge
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: weiwei Wu, MD, Beijing Tsinghua Changgeng Hospital
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 2D-EIT-PE-2026
- L246021 (Número de outro subsídio/financiamento: Beijing Natural Science Foundation-Daxing Innovation Joint Fund)
- 26890-0-01 (Outro identificador: Institutional Review Board of Beijing Tsinghua Changgung Hospital)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .